 | Up a level |
Journal Article
Roesel, K., Schneider, C., Kobe, C., Dietlein, M., Drzezga, A. and Schmidt, M. C. (2015). Tc-99m MIBI-scintigraphy for malignancy risk assessment of hypofunctionning thyroid nodules. Eur. J. Nucl. Med. Mol. Imaging, 42. S. S66 - 2. NEW YORK: SPRINGER. ISSN 1619-7089
Schmidt, M. C., Hero, B., Decarolis, B., Eggert, A., Berthold, F., Drzezga, A. and Simon, T. (2017). I-131-mIBG therapy in high-risk neuroblastoma patients at end of induction chemotherapy. Eur. J. Nucl. Med. Mol. Imaging, 44. S. S772 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Schmidt, M. C., Hero, B., Decarolis, B., Eggert, A., Berthold, F., Drzezga, A. and Simon, T. (2016). I-131-meta-iodobenzylguanidine therapy improves survival in high-risk neuroblastoma patients with I-123-mIBG positive residual metastatic disease. Eur. J. Nucl. Med. Mol. Imaging, 43. S. S31 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Schmidt, M. C., Pfister, O., Kobe, C., Dietlein, M., Dietlein, M., Heidenreich, A. and Drzezga, A. (2017). Tc-99m-PSMA-guided intraoperative lymph node localization in recurrent prostate cancer. Eur. J. Nucl. Med. Mol. Imaging, 44. S. S750 - 2. NEW YORK: SPRINGER. ISSN 1619-7089